Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion

Cell Signal. 2017 Oct:38:49-59. doi: 10.1016/j.cellsig.2017.06.016. Epub 2017 Jun 24.

Abstract

Atypical protein kinase C ζ (PKCζ) forms an apico-basal polarity complex with Partitioning Defective (Pard) 3 and Pard6 to regulate normal epithelial cell apico-basolateral polarization. The dissociation of the PKCζ/Pard3/Pard6 complex is essential for the disassembly of the tight/adherens junction and epithelial-mesenchymal transition (EMT) that is critical for tumor spreading. Loss of cell polarity and epithelial organization is strongly correlated with malignancy and tumor progression in some other cancer types. However, it is unclear whether the PKCζ/Pard3/Pard6 complex plays a role in the progression of non-small-cell lung cancer (NSCLC). We found that hypoxia downregulated the PKCζ/Pard3/Pard6 complex, correlating with induction of lung cancer cell migration and invasion. Silencing of the PKCζ/Pard3/Pard6 polarity complex components induced lung cancer cell EMT, invasion, and colonization in vivo. Suppression of Pard3 was associated with altered expression of genes regulating wound healing, cell apoptosis/death and cell motility, and particularly upregulation of MAP3K1 and fibronectin which are known to contribute to lung cancer progression. Human lung adenocarcinoma tissues expressed less Pard6b and PKCζ than the adjacent normal tissues and in experimental mouse lung adenocarcinoma, the levels of Pard3 and PKCζ were also decreased. In addition, we showed that a methylation locus in the gene body of Pard3 is positively associated with the expression of Pard3 and that methylation of the Pard3 gene increased cellular sensitivity to carboplatin, a common chemotherapy drug. Suppression of Pard3 increased chemoresistance in lung cancer cells. Together, these results suggest that reduced expression of PKCζ/Pard3/Pard6 contributes to NSCLC EMT, invasion, and chemoresistance.

Keywords: Epithelial-mesenchymal transition; Hypoxia; Invasion; Lung cancer; PKCζ/Pard3/Pard6 polarity complex.

MeSH terms

  • A549 Cells
  • Adaptor Proteins, Signal Transducing / metabolism*
  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / pathology*
  • Adenocarcinoma of Lung
  • Animals
  • Carboplatin / pharmacology
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Cell Cycle Proteins / metabolism*
  • Cell Hypoxia / drug effects
  • Cell Movement / drug effects
  • Cell Polarity / drug effects
  • Cisplatin / pharmacology
  • Down-Regulation / drug effects
  • Drug Resistance, Neoplasm / drug effects
  • Epithelial-Mesenchymal Transition* / drug effects
  • Fibronectins / metabolism
  • Gene Silencing / drug effects
  • Humans
  • Lung / drug effects
  • Lung / metabolism
  • Lung / pathology
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / pathology*
  • MAP Kinase Kinase Kinase 1 / metabolism
  • Membrane Proteins / metabolism*
  • Mice, Nude
  • Neoplasm Invasiveness
  • Protein Kinase C / metabolism*

Substances

  • Adaptor Proteins, Signal Transducing
  • Cell Cycle Proteins
  • Fibronectins
  • Membrane Proteins
  • PARD3 protein, human
  • PARD6B protein, human
  • Carboplatin
  • protein kinase C zeta
  • Protein Kinase C
  • MAP Kinase Kinase Kinase 1
  • Cisplatin